By encoding IRF5 together with its activating kinase IKKβ, TAMs were reprogrammed to trigger anti-tumor response and facilitated tumor cell death after infused of nanoparticles formulated with mRNAs to reverse their immunosuppressive, tumor-supporting state. The gene discussed is IRF5; the disease is neoplasm.